Centersquare Investment Management LLC Invests $50.28 Million in Sabra Healthcare REIT, Inc. $SBRA

Centersquare Investment Management LLC acquired a new position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,654,480 shares of the real estate investment trust’s stock, valued at approximately $50,276,000.

Several other large investors also recently modified their holdings of the company. PNC Financial Services Group Inc. increased its position in shares of Sabra Healthcare REIT by 2.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust’s stock worth $451,000 after buying an additional 528 shares during the period. Larson Financial Group LLC boosted its stake in Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 553 shares in the last quarter. Anchor Investment Management LLC boosted its stake in Sabra Healthcare REIT by 15.5% during the third quarter. Anchor Investment Management LLC now owns 4,150 shares of the real estate investment trust’s stock worth $77,000 after acquiring an additional 556 shares in the last quarter. Oppenheimer & Co. Inc. boosted its stake in Sabra Healthcare REIT by 1.7% during the third quarter. Oppenheimer & Co. Inc. now owns 33,984 shares of the real estate investment trust’s stock worth $633,000 after acquiring an additional 581 shares in the last quarter. Finally, Journey Strategic Wealth LLC boosted its stake in Sabra Healthcare REIT by 3.3% during the third quarter. Journey Strategic Wealth LLC now owns 18,479 shares of the real estate investment trust’s stock worth $344,000 after acquiring an additional 595 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

SBRA has been the topic of several research analyst reports. Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Monday, May 18th. Truist Financial increased their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research note on Friday, March 13th. Citigroup increased their target price on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, February 18th. Citizens Jmp increased their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a research note on Wednesday, February 18th. Finally, UBS Group increased their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 13th. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $22.40.

Sabra Healthcare REIT Stock Down 1.8%

Shares of NASDAQ SBRA opened at $18.49 on Friday. The firm has a market cap of $4.66 billion, a PE ratio of 29.35, a P/E/G ratio of 1.40 and a beta of 0.64. Sabra Healthcare REIT, Inc. has a 12-month low of $17.17 and a 12-month high of $21.28. The company’s fifty day simple moving average is $20.08 and its 200 day simple moving average is $19.69. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.16. The firm had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The business’s revenue was up 20.9% on a year-over-year basis. During the same period last year, the company earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.5%. The ex-dividend date was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 190.48%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.